INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES. CMN [Internet]. 2024 Aug. 8 [cited 2026 Nov. 6];6(2):3635-42. Available from: https://cahiersmagellanes.com/index.php/CMN/article/view/633